Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,824.00
Bid: 1,816.00
Ask: 1,826.00
Change: -16.00 (-0.87%)
Spread: 10.00 (0.551%)
Open: 1,870.00
High: 1,870.00
Low: 1,814.00
Prev. Close: 1,840.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

15 Nov 2007 07:01

Genus PLC15 November 2007 For Immediate Release 15 November 2007 Genus plc Annual General Meeting At the Annual General Meeting of Genus plc ("Genus") to be held today at 2.30pm,the Chairman, John Hawkins, will make the following statement: "During the financial year to 30 June 2007, the first full year since wecompleted the Sygen acquisition that so dramatically changed the potential ofthe Company, we have achieved strong business growth and increased cost productivity by successfully integrating the acquired business. In the years tocome, Genus' progress will continue to benefit from the increased opportunitiesarising from that acquisition. In the Annual Report and Financial Statements for last year's trading, weconfirmed the Board's intention to divest the remaining non-core businesses todrive down debt, while ensuring that such divestments would realise goodshareholder value. We also stated that we would continue to seek to increaseliquidity in Genus shares. In these pursuits, in October, we completed the sale of the only remainingshrimp business, SyAqua Mexico and last week, we announced the disposal ofHTSPE, the Development Consulting business. To increase liquidity in Genus shares and to reduce debt, on 6 November, weannounced that we had raised £19.4m from placing 2.7 million shares withinstitutions at £7.20 per share. This placing is expected to be earningsenhancing as it reduces group debt to below £100m, thereby reducing the Group'saverage interest costs by 25 basis points. Also to improve liquidity, in parallel, we concluded a small shareholder buy-back and placing with institutional shareholders, for a total of 1.15 millionshares at a price of up to £7.30 per share. 1,692 small shareholders in Genustook advantage of this low cost dealing mechanism. Trading for the new financial year has started well in the anticipated improvingagricultural climate. For the first quarter, trading has been on plan, despitethe weakening dollar. While we expect some uncertainty to continue in Europe,as the industry adjusts to the challenges of a changing environment, buoyancy inother markets should more than compensate for this. The Board was delighted to announce, on 12 November, the admission of trading inGenus' shares to the Official List of the London Stock Exchange. Genus wasoriginally formed when the Milk Marketing Board was privatised in 1994 and firsttraded as a Public Company on OFEX in 1997, progressing to AIM in 2000. Nowwith a Market Capitalisation of around £420m, Genus is ranked at about 350 ofthe leading FTSE companies. In closing my review, I would like to offer my thanks to my colleagues on theBoard for their support in our achievements, over the last 10 years, butparticularly for this year. With the Company's move to the Official List, Edwin White, the Company's senior non-executive director, has indicated hisintention to leave the Board during the current financial year and the Companyis in the process of recruiting Mr White's successor. I would also like to compliment the management team and the staff at Genus fortheir achievements over this ten year period of considerable change anddevelopment of the company. The Board believes we have created a company with considerable market strength,good R&D, proven skills in managing both organic and acquisition growth andoperating cost advantages from integrating the recent acquisition. This bodes well for the future of Genus in improving market conditions. To conclude, I would like to offer the Board's commitment to Genus' shareholdersthat, as we begin a new chapter in the development of Genus as a ListedCompany, we will continue to build on the success that we have so far achieved." For further information please contact: Genus plc Tel: 01256 347 100Richard Wood, Chief ExecutiveMartin Boden, Finance Director Landsbanki Securities (UK) Limited Tel: 020 7426 9000Financial Advisor & Joint BrokerShaun Dobson Panmure Gordon (UK) Limited Tel: 020 7459 3600Joint BrokerMark Lander Buchanan Communications Tel: 020 7466 5000Charles RylandSuzanne BrocksChristian Goodbody This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Feb 20132:30 pmRNSTotal Voting Rights
28th Feb 20132:00 pmRNSDirector/PDMR Shareholding
25th Feb 20134:21 pmRNSDirector/PDMR Shareholding
25th Feb 20137:00 amRNSInterim Results
25th Feb 20137:00 amRNSSecond New Joint Venture in China
4th Feb 201310:00 amRNSHolding(s) in Company
31st Jan 20132:00 pmRNSBlocklisting Interim Review
31st Jan 20132:00 pmRNSTotal Voting Rights
8th Jan 20132:00 pmRNSHolding(s) in Company
13th Dec 20127:00 amRNSDirectorate Change
7th Dec 201210:00 amRNSDirector/PDMR Shareholding
30th Nov 20122:00 pmRNSTotal Voting Rights
14th Nov 201210:00 amRNSHolding(s) in Company
8th Nov 20123:30 pmRNSAGM Statement
8th Nov 20127:00 amRNSAGM and Interim Management Statement
31st Oct 20122:03 pmRNSTotal Voting Rights
26th Oct 201210:00 amRNSHolding(s) in Company
17th Oct 201210:00 amRNSHolding(s) in Company
9th Oct 20122:00 pmRNSAnnual Report and details of AGM
28th Sep 20122:00 pmRNSTotal Voting Rights
27th Sep 201211:00 amRNSAdditional Listing
27th Sep 20128:00 amRNSHolding(s) in Company
26th Sep 20124:01 pmRNSDirector/PDMR Shareholding
4th Sep 20127:00 amRNSPreliminary Results
31st Aug 20122:00 pmRNSTotal Voting Rights
23rd Aug 20126:18 pmRNSHolding(s) in Company
20th Aug 20127:00 amRNSAppointment of Joint Broker
31st Jul 20122:00 pmRNSBlocklisting Interim Review
31st Jul 20122:00 pmRNSTotal Voting Rights
31st Jul 20127:00 amRNSJoint Venture in China
4th Jul 20127:00 amRNSPre-Close Trading Statement
15th May 20124:09 pmRNSHolding(s) in Company
15th May 20124:08 pmRNSHolding(s) in Company
3rd May 20127:00 amRNSInterim Management Statement and Strategy Update
30th Apr 20122:00 pmRNSTotal Voting Rights
30th Mar 20122:00 pmRNSTotal Voting Rights
14th Mar 20122:00 pmRNSDirector/PDMR Shareholding
29th Feb 20122:00 pmRNSTotal Voting Rights
27th Feb 20124:25 pmRNSHolding(s) in Company
21st Feb 20123:16 pmRNSHolding(s) in Company
21st Feb 20122:30 pmRNSDirector/PDMR Shareholding
21st Feb 20127:00 amRNSInterim Results
31st Jan 20122:00 pmRNSBlocklisting Interim Review
31st Jan 201210:44 amRNSNotice of Results
16th Jan 20123:49 pmRNSHolding(s) in Company
4th Jan 20127:00 amRNSSenior Management Changes
30th Dec 201112:00 pmRNSTotal Voting Rights
30th Nov 20112:00 pmRNSTotal Voting Rights
10th Nov 201112:51 pmRNSResult of AGM
10th Nov 20117:00 amRNSAGM and Interim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.